Medicare Enrolled
Dr. Ashley Chin, M.D.
Family Medicine · Magnolia, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Chin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Chin
Dr. Ashley Chin is a family medicine specialist in Magnolia, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Chin performed 2,140 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Chin received a total of $12,641 from 71 pharmaceutical and/or device companies across 751 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Chin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 13% volume in TX
$12,641 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,140
Medicare services
Top 13% in TX for family medicine
Not available
Unique patients (not deduplicated)
$55
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
495 | $85 | $150 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
466 | $61 | $115 |
| Annual alcohol misuse screening, 5 to 15 minutes | 159 | $18 | $30 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
155 | $3 | $10 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
155 | $126 | $175 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
153 | $0 | $20 |
| Annual depression screening | 148 | $18 | $30 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
68 | $10 | $30 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
56 | $24 | $25 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
50 | $10 | $50 |
| Methylprednisolone acetate injection, 20 mg A 20 mg injection of methylprednisolone acetate, a corticosteroid medication. This code specifies the drug and dosage administered. |
43 | $5 | $10 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
37 | $76 | $80 |
| Annual intensive behavioral therapy for cardiovascular disease, 15 minutes A yearly, in-person session focused on intensive behavioral therapy to help manage cardiovascular disease. The session lasts for 15 minutes and is conducted with the patient individually. |
34 | $25 | $40 |
| Initial preventive physical examination, new Medicare beneficiary A comprehensive preventive health visit for new Medicare beneficiaries during their first 12 months of enrollment. The service is conducted as a face-to-face visit and is limited to preventive care. |
23 | $161 | $175 |
| Quadrivalent influenza vaccine, cell-culture derived A flu shot containing four strains of influenza virus, produced using cell culture technology rather than eggs. This formulation is free from preservatives and antibiotics. |
20 | $33 | $40 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
20 | $58 | $120 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
18 | $282 | $350 |
| Annual wellness visit, initial visit A yearly appointment to review your health and create a personalized prevention plan. This initial visit focuses on preventive care and health assessment. |
16 | $161 | $180 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
12 | $118 | $190 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
12 | $24 | $25 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$12,641
Total received (2018-2024)
Avg $1,806/year across 7 years
Top 3% in TX for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
71
Companies
751
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,690
2023
$1,965
2022
$1,548
2021
$1,266
2020
$656
2019
$2,656
2018
$2,860
Payments by company (2024)
Novo Nordisk Inc
$250
ABBVIE INC.
$239
AstraZeneca Pharmaceuticals LP
$209
PFIZER INC.
$192
Bayer Healthcare Pharmaceuticals Inc.
$147
Lilly USA, LLC
$147
Amgen Inc.
$88
Radius Health, Inc.
$64
Currax Pharmaceuticals LLC
$44
MILLICENT US INC
$41
Astellas Pharma US Inc
$38
Bausch Health US, LLC
$34
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$33
Acella Pharmaceuticals, LLC
$25
Otsuka America Pharmaceutical, Inc.
$24
Exact Sciences Corporation
$23
Esperion Therapeutics, Inc.
$20
Merck Sharp & Dohme LLC
$20
Abbott Laboratories
$19
Lundbeck LLC
$19
Tolmar, Inc.
$14
Top 3 companies account for 41.3% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$1,971
Lilly USA, LLC
$975
AstraZeneca Pharmaceuticals LP
$950
Amgen Inc.
$664
ABBVIE INC.
$611
AbbVie Inc.
$597
PFIZER INC.
$473
SANOFI-AVENTIS U.S. LLC
$431
Takeda Pharmaceuticals U.S.A., Inc.
$409
Merck Sharp & Dohme Corporation
$363
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$329
Abbott Laboratories
$273
Bayer Healthcare Pharmaceuticals Inc.
$262
Astellas Pharma US Inc
$239
Boehringer Ingelheim Pharmaceuticals, Inc.
$223
Shire North American Group Inc
$220
Allergan Inc.
$202
Teva Pharmaceuticals USA, Inc.
$202
Janssen Pharmaceuticals, Inc
$163
Otsuka America Pharmaceutical, Inc.
$158
ARBOR PHARMACEUTICALS, INC.
$155
Bausch Health US, LLC
$153
Merz North America, Inc.
$149
Kowa Pharmaceuticals America, Inc.
$140
Radius Health, Inc.
$136
Antares Pharma, Inc.
$134
GlaxoSmithKline, LLC.
$114
Biohaven Pharmaceutical Holding Company Ltd.
$108
Endo Pharmaceuticals Inc.
$102
Dexcom, Inc.
$102
Currax Pharmaceuticals LLC
$98
Exact Sciences Corporation
$98
Avanir Pharmaceuticals, Inc.
$89
Valeritas, Inc.
$74
Corcept Therapeutics
$65
Horizon Therapeutics plc
$62
Mannkind Corporation
$59
Vertiflex, Inc.
$58
Tolmar, Inc.
$56
Supernus Pharmaceuticals, Inc.
$56
Allergan, Inc.
$55
Merck Sharp & Dohme LLC
$54
AMAG Pharmaceuticals, Inc.
$52
IBSA Pharma Inc.
$52
Galderma Laboratories, L.P.
$46
Novartis Pharmaceuticals Corporation
$44
Xeris Pharmaceuticals, Inc.
$43
MILLICENT US INC
$41
Amarin Pharma Inc.
$38
Acerus Pharmaceuticals Corporation
$38
Esperion Therapeutics, Inc.
$38
MannKind Corporation
$32
Orexigen Therapeutics, Inc.
$29
Bayer HealthCare Pharmaceuticals Inc.
$29
Tandem Diabetes Care, Inc.
$27
Amneal Pharmaceuticals LLC
$25
Acella Pharmaceuticals, LLC
$25
Daiichi Sankyo Inc.
$24
Althera Pharmaceuticals LLC
$24
Intuity Medical Inc
$21
AbbVie, Inc.
$21
Clarus Therapeutics Inc.
$20
Lundbeck LLC
$19
Biohaven Pharmaceuticals, Inc.
$18
Genentech USA, Inc.
$17
Lupin Inc.
$17
SCYNEXIS, Inc.
$17
Nalpropion Pharmaceuticals LLC
$16
Adlon Therapeutics L.P.
$14
Nalpropion Pharmaceuticals, Inc.
$13
Upsher-Smith Laboratories LLC
$13
Top 3 companies account for 30.8% of all-time payments
Associated products mentioned in payments ›
ADHANSIA XR · AFREZZA · AIRSUPRA · AJOVY · APLENZIN · Aimovig · Amitiza · BAQSIMI · BASAGLAR · BELSOMRA · BEVESPI AEROSPHERE · BREZTRI · BYSTOLIC · CHANTIX · COMIRNATY · CONTRAVE · CYCLOSET · Cologuard Collection Kit · Dexcom G6 Transmitter · ELIGARD · EMGALITY · EUCRISA · EVENITY · Edarbi · FARXIGA · FASENRA · FEMRING · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · GARDASIL · GARDASIL 9 · GVOKE HYPOPEN · GVOKE PFS · INJECTAFER · INTRAROSA · INVOKANA · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LEQVIO · LINZESS · Livalo · MOUNJARO · MOVANTIK · MYDAYIS · MYRBETRIQ · Myrbetriq · NASCOBAL · NATPARA · NEXLETOL · NOCDURNA · NP Thyroid 60 · NUEDEXTA · NURTEC ODT · Natesto · ONZETRA XSAIL · ONZETRA Xsail · OTREXUP · Otezla · Otovel · Otrexup · Ozempic · PAXLOVID · PNEUMOVAX 23 · PREVNAR - 13 · PREVNAR 20 · Pogo Automatic Blood Glucose Monitoring System · Proclaim IPG · Prolia · QULIPTA · REXULTI · REYVOW · ROTATEQ · RYBELSUS · Repatha · Roszet · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SOLOSEC · SPIRIVA RESPIMAT · SYMBICORT · SYNTHROID · Saxenda · Superion ISS · Synthroid · TEPEZZA · TLANDO · TOSYMRA SUMATRIPTAN NASAL SPRAY · TOUJEO · TOVIAZ · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TROKENDI XR · TRULICITY · Tirosint · Tresiba · Trintellix · Tymlos · UBRELVY · UNITHROID · V-GO · VRAYLAR · VYLEESI · VYVANSE · Vascepa · Veozah · Victoza · WELLBUTRIN · Wegovy · XARELTO · XIFAXAN · XYOSTED · Xofluza · ZOSTAVAX · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Family medicine physicians in nearby ZIP areas
521
County median income
$97,266
Nearest hospital to ZIP centroid (approximate)
HCA HOUSTON HEALTHCARE TOMBALL
8.5 mi
8.5 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Chin is a clinical cardiology specialist, with above-average Medicare volume (top 13% in TX), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Chin experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Chin performed 495 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Chin receive payments from pharmaceutical companies?
Yes. Dr. Chin received a total of $12,641 from 71 companies across 751 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chin's costs compare to other family medicine physicians in Magnolia?
Dr. Chin's average Medicare payment per service is $55. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Magnolia
Browse family medicine physicians in Magnolia ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in TX
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in TX
Which TX family medicine physicians receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology